Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Filings indexed 1,687 across all filing types
Latest filing 2024-05-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 1786

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations. It is very short (785 characters) and contains no detailed financial statements or comprehensive analysis. It is a brief financial data disclosure, typical of a Fund Information / Factsheet (FS) or a brief financial summary. It is not an annual or interim report, nor an earnings release since it lacks key highlights or narrative. Given the concise nature and focus on revenue figures, the best fit is Fund Information / Factsheet (FS).
2024-05-09 Chinese
113年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first quarter of the fiscal year 2024 (民國113年第1季) and the same period last year. It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, and total equity attributable to the parent company and non-controlling interests. The presence of actual financial figures and comparative periods indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 3396 characters, which is relatively short but contains detailed financial tables, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the 113th year (which corresponds to 2024) and compares it with the same period in the previous year. It includes detailed financial data such as net profit before tax, depreciation, amortization, changes in assets and liabilities, and cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a quarterly financial report. The document length is 2077 characters, which is sufficient to contain actual financial data, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the 113th year (which corresponds to 2024) and compares it with the same period in the previous year. It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 1975 characters, which is sufficient to contain financial data, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple dates, including the first quarter of 2024 (民國113年第1季). It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, and equity. The presence of actual financial figures and the quarterly period indicate this is a financial report for a period shorter than a full fiscal year. The document length is under 5,000 characters but contains substantive financial data, so it is not merely an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
公告本公司國內第二次無擔保轉換公司債113年第1季轉換 普通股之發行新股基準日
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the issuance of new shares due to the conversion of domestic unsecured convertible bonds. It includes details such as the board resolution date, amount and number of shares issued, capital increase, and related procedural information. There is no financial report, earnings data, or management discussion. The content fits the category of announcements related to share issuance or capital changes rather than a full report or regulatory filing. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not a report publication announcement or regulatory filing fallback.
2024-05-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.